Aspartate aminotransferase to platelet ratio index as a prospective predictor of hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection

Journal of Gastroenterology and Hepatology (Australia)

Volumn 30, Issue 1, 2015, Pages 131-138

  Hann, Hie Won ^a   Wan, Shaogui ^b,c   Lai, Yinzhi ^b   Hann, Richard S ^a   Myers, Ronald E ^b   Patel, Fenil ^b   Zhang, Kejin ^b   Ye, Zhong ^b   Wang, Chun ^b   Yang, Hushan ^b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c HENAN UNIVERSITY   (China)

Author keywords

APRI; HBV; HCC

Indexed keywords

ADEFOVIR DIPIVOXIL; ASPARTATE AMINOTRANSFERASE; ENTECAVIR; INTERFERON; LAMIVUDINE; TELBIVUDINE; TENOFOVIR DISOPROXIL; BIOLOGICAL MARKER;

ADD ON THERAPY; ADULT; ANTIVIRAL THERAPY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE TO PLATELET RATIO INDEX; BLOOD CELL RATIO; CANCER INCIDENCE; CANCER PATIENT; CANCER RISK; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FUNCTION TEST; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; MONOTHERAPY; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK FACTOR; TREND STUDY; UNIVARIATE ANALYSIS; AGED; BLOOD; CARCINOMA, HEPATOCELLULAR; COMPLICATION; LIVER NEOPLASMS; RISK; THROMBOCYTE COUNT; YOUNG ADULT;

ADULT; AGED; ASPARTATE AMINOTRANSFERASES; BIOMARKERS; CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; FEMALE; HEPATITIS B, CHRONIC; HUMANS; LIVER NEOPLASMS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PLATELET COUNT; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK; YOUNG ADULT;

EID: 84919662333     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12664     Document Type: Article

References (25)

1. El-Serag HB. Hepatocellular carcinoma. N. Engl. J. Med. 2011; 365: 1118-1127.
2. Altekruse SF, McGlynn KA, Reichman ME. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J. Clin. Oncol. 2009; 27: 1485-1491.
3. Blum HE. Hepatocellular carcinoma: therapy and prevention. World J. Gastroenterol. 2005; 11: 7391-7400.
4. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005; 42: 1208-1236.
5. Baranova A, Lal P, Birerdinc A, Younossi ZM. Non-invasive markers for hepatic fibrosis. BMC Gastroenterol. 2011; 11: 91.
6. Shaheen AA, Myers RP. Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis C-related fibrosis: a systematic review. Hepatology 2007; 46: 912-921.
7. Wai CT, Greenson JK, Fontana RJ etal. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003; 38: 518-526.
8. Lebensztejn DM, Skiba E, Sobaniec-Lotowska M, Kaczmarski M. A simple noninvasive index (APRI) predicts advanced liver fibrosis in children with chronic hepatitis B. Hepatology 2005; 41: 1434-1435.
9. Shin WG, Park SH, Jang MK etal. Aspartate aminotransferase to platelet ratio index (APRI) can predict liver fibrosis in chronic hepatitis B. Dig. Liver Dis. 2008; 40: 267-274.
10. Lin CS, Chang CS, Yang SS, Yeh HZ, Lin CW. Retrospective evaluation of serum markers APRI and AST/ALT for assessing liver fibrosis and cirrhosis in chronic hepatitis B and C patients with hepatocellular carcinoma. Intern. Med. 2008; 47: 569-575.
11. Hung HH, Su CW, Lai CR etal. Fibrosis and AST to platelet ratio index predict post-operative prognosis for solitary small hepatitis B-related hepatocellular carcinoma. Hepatol. Int. 2010; 4: 691-699.
12. Wan S, Hann HW, Myers RE etal. Telomere length in circulating serum DNA as a novel non-invasive biomarker for cirrhosis: a nested case-control analysis. Liver Int. 2012; 32: 1233-1241.
13. Fu X, Wan S, Hann HW etal. Relative telomere length: a novel non-invasive biomarker for the risk of non-cirrhotic hepatocellular carcinoma in patients with chronic hepatitis B infection. Eur. J. Cancer 2012; 48: 1014-1022.
14. Ruhl CE, Everhart JE. Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population. Gastroenterology 2009; 136: 477-485. e11.
15. Hann HW, Wan S, Myers RE etal. Comprehensive analysis of common serum liver enzymes as prospective predictors of hepatocellular carcinoma in HBV patients. PLoS ONE 2012; 7: e47687.
16. Hann HW, Fu X, Myers RE etal. Predictive value of alpha-fetoprotein in the long-term risk of developing hepatocellular carcinoma in patients with hepatitis B virus infection-results from a clinic-based longitudinal cohort. Eur. J. Cancer 2012; 48: 2319-2327.
17. Yu ML, Lin SM, Lee CM etal. A simple noninvasive index for predicting long-term outcome of chronic hepatitis C after interferon-based therapy. Hepatology 2006; 44: 1086-1097.
18. Lieber CS, Weiss DG, Morgan TR, Paronetto F. Aspartate aminotransferase to platelet ratio index in patients with alcoholic liver fibrosis. Am. J. Gastroenterol. 2006; 101: 1500-1508.
19. Wai CT, Cheng CL, Wee A etal. Non-invasive models for predicting histology in patients with chronic hepatitis B. Liver Int. 2006; 26: 666-672.
20. Cales P, Oberti F, Michalak S etal. A novel panel of blood markers to assess the degree of liver fibrosis. Hepatology 2005; 42: 1373-1381.
21. Kao WY, Chiou YY, Hung HH etal. Risk factors for long-term prognosis in hepatocellular carcinoma after radiofrequency ablation therapy: the clinical implication of aspartate aminotransferase-platelet ratio index. Eur. J. Gastroenterol. Hepatol. 2011; 23: 528-536.
22. Kawamura Y, Arase Y, Ikeda K etal. Large-scale long-term follow-up study of Japanese patients with non-alcoholic fatty liver disease for the onset of hepatocellular carcinoma. Am. J. Gastroenterol. 2012; 107: 253-261.
23. de Lope CR, Tremosini S, Forner A, Reig M, Bruix J. Management of HCC. J. Hepatol. 2012; 56 (Suppl. 1): S75-87.
24. Kojiro M, Roskams T. Early hepatocellular carcinoma and dysplastic nodules. Semin. Liver Dis. 2005; 25: 133-142.
25. Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology 2011; 53: 1020-1022.